San Diego-based mostly Viking Therapeutics marked alone as a serious competitor while in the weight loss drug industry in February immediately after revealing promising facts from the mid-phase demo of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection and in Marc